Pacific Edge's (PEB) 2Q25 update showed expected softness in lab throughput trends. 2Q25 tests of 7,045 was down -17% versus 2Q24, and slightly below our 7,300 forecast.
What is covered in the Full Insight:
Introduction
Current Performance Overview
Financial Health and Equity Needs
Impact of LCD Decision
Valuation and Price Targets
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.